
Otsuka NS Flexidrip 0.9% Injection
Marketer
Otsuka Pharmaceuticals Pvt Ltd
Salt Composition
Sodium Chloride (0.9% w/v)
Overview Otsuka NS Flexidrip 0.9% Injection
Otsuka NS Flexidrip 0.9% Injection, a sterile saline solution, provides short-term fluid replacement therapy. It addresses hypovolemia stemming from dehydration or trauma by replenishing vital electrolytes and sodium. Administration requires qualified medical oversight. Prior to use, disclose any allergies to the injection or pre-existing kidney conditions, as dosage modifications might be necessary. Pregnancy or breastfeeding should also be reported. This injection effectively restores fluid balance and is suitable for patients with liver disease. Common side effects, including injection site inflammation, low blood pressure, fever, tremors, and chills, may occur; report any persistent or concerning reactions to your physician. Regular blood tests and blood pressure monitoring may be recommended during treatment.
Uses of Otsuka NS Flexidrip 0.9% Injection
Rehydration therapy for acute fluid loss following injury or dehydration.
Major Benefits of Otsuka NS Flexidrip 0.9% Injection:
Administering this medication will be done by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Otsuka NS Flexidrip 0.9% Injection:
- Injection site reactions (pain, swelling, redness)
- Hypotension (low blood pressure)
- Fever
- Tremors
- Chills
How to use Otsuka NS Flexidrip 0.9% Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Otsuka NS Flexidrip 0.9% Injection lacks established safety data. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Otsuka NS Flexidrip 0.9% Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against potential hazards prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Otsuka NS Flexidrip 0.9% Injection with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Administering Otsuka NS Flexidrip 0.9% Injection may induce drowsiness, blurred vision, and dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
Exercise caution when administering Otsuka NS Flexidrip 0.9% Injection to individuals with impaired renal function. Dosage modification of Otsuka NS Flexidrip 0.9% Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Otsuka NS Flexidrip 0.9% Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary for this patient population. Physician consultation is recommended.
What if you forget to take Otsuka NS Flexidrip 0.9% Injection :
Omitting a dose of Otsuka NS Flexidrip 0.9% Injection necessitates contacting your physician.
Facts to Know About Otsuka NS Flexidrip 0.9% Injection
| Label | Value |
|---|---|
| Chemical Type | Chlorides of Alkali Metals |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
